In vitro biotransformation of OA-group and PTX-group toxins in visceral and non-visceral tissues of Mytilus chilensis and Ameghinomya antiqua
Author
dc.contributor.author
Oyaneder Terrazas, Javiera
Author
dc.contributor.author
Polanco, Cassandra
Author
dc.contributor.author
Figueroa, Diego
Author
dc.contributor.author
Barriga, Andrés
Author
dc.contributor.author
García, Carlos
Admission date
dc.date.accessioned
2020-08-08T01:30:08Z
Available date
dc.date.available
2020-08-08T01:30:08Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Food Additives & Contaminants: Part A 2020, Vol. 37, No. 7, 1216–1228
es_ES
Identifier
dc.identifier.other
10.1080/19440049.2020.1750710
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/176364
Abstract
dc.description.abstract
Lipophilic marine toxins (LMTs) are made up of multiple groups of toxic analogues, which are
characterised by different levels of cellular and toxic action. The most prevalent groups in the
southern Pacific zone are: a) okadaic acid group (OA-group) which consists of okadaic acid (OA) and
dinophysistoxin-1 (DTX-1); and, b) pectenotoxin-2 (PTX2) group which consists of pectenotoxin-2
(PTX-2). The main objective of our study was to examine in vitro biotransformation of OA-group
and PTX-group in the tissues of two endemic species of bivalves from southern Chile; blue mussels
(Mytilus chilensis) and clams (Ameghinomya antiqua). The biotransformation processes of both
groups were only detected in the digestive glands of both species using LC-MS/MS. The most
frequently detected analogues were acyl derivatives (≈2.0 ± 0.1 μg ml−1) for OA-group and PTX-2SA
(≈1.4 ± 0.1 μg ml−1) for PTX-group, with a higher percentage of biotransformation for OA-group
(p < .001). In addition, simultaneous incubations of the different analogues (OA/PTX-2; DTX-1/PTX-2
and OA/DTX-1/PTX-2) did not show any interaction between the biotransformation processes.
These results show that the toxicological variability of endemic species leads to biotransformation
of the profile of toxins, so that these new analogues may affect people’s health.